Disseminated cutaneous sporotrichosis treated with itraconazole

Cutis

Volumn 69, Issue 5, 2002, Pages 371-374

  Stalkup, Jennifer R ^a   Bell, Katherine ^a   Rosen, Ted ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ARTICLE; CASE REPORT; DIABETES MELLITUS; HUMAN; MALE; SPOROTRICHOSIS;

ANTIFUNGAL AGENTS; DIABETES COMPLICATIONS; HUMANS; ITRACONAZOLE; MALE; SPOROTRICHOSIS;

EID: 0036583662     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Belknap BS. Sporotrichosis. Dermatol Clin. 1989;7:193-202.
2. Ware AJ, Cockerell CJ, Skiest DJ, et al. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol. 1999;40:350-355.
3. Campos P, Arenas R, Coronado H. Epidemic cutaneous sporotrichosis. Int J Dermatol. 1994;33:38-41.
4. Morgan MA, Cockerill FR 3rd, Cortese DA, et al. Disseminated sporotrichosis with Sporothrix schenckii fungemia. Diagn Microbiol Infect Dis. 1984;2:151-155.
5. Velji AM, Hoeprich PD, Slovak R. Multifocal systemic sporotrichosis with lobar pulmonary involvement. Scand Infect Dis. 1988;20:265-269.
6. Edwards C, Reuther WL 3rd, Greer DL. Disseminated osteoarticular sporotrichosis: treatment in a patient with acquired immunodeficiency syndrome. South Med J. 2000;93:803-806.
7. Donabedian H, O'Donnell E, Olszewski C, et al. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18:111-115.
8. Gullberg RM, Quintanilla A, Levin ML, et al. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant patient. Rev Infect Dis. 1987;9:369-375.
9. Goveia GL, Bellome J, Hiatt WR. Disseminated sporotrichosis with mandibular involvement. J Oral Surg. 1981;39:468-472.
10. Wilson DE, Mann JJ, Bennett JE. Clinical features of extracutaneous sporotrichosis. Medicine. 1967;46:265-279.
11. Everett MA. Atypical sporotrichosis. J Okla State Med Assoc. 1963;56:483-485.
12. Goldani LZ, Aquino VR, Dargel AA. Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis. Clin Infect Dis. 1999;28:1337-1338.
13. Cullen SI, Mauceri AA, Warner N. Successful treatment of disseminated cutaneous sporotrichosis with ketoconazole. J Am Acad Dermatol. 1992;27:463-464.
14. Addy JH. Disseminated cutaneous sporotrichosis associated with anergic immunosuppression due to miliary tuberculosis. West Afr J Med. 1992;11:216-220.
15. Smith PW, Loomis GW, Luckasen JL, et al. Disseminated cutaneous sporotrichosis. Arch Dermatol. 1981;117:143-144.
16. Kurosawa A, Pollock SC, Collins MP, et al. Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection. Arch Ophthalmol. 1988;106:376-380.
17. Plouffe JR, Silva J Jr, Fekety R. Cell-mediated immune responses in sporotrichosis. J Infect Dis. 1979;139:152-157.
18. al-Tawfiq, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26:1403-1406.
19. Aronson NE. Disseminated sporotrichosis. JAMA. 1992;268:2021.
20. Oscherwitz SL, Rinaldi MG. Disseminated sporotrichosis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1992;15:568-569.
21. Bibler MR, Luber HJ, Glueck HI, et al. Disseminated sporotrichosis in a patient with HIV infection after treatment for acquired factor VIII inhibitor. JAMA. 1986;256:3125-3126.
22. Shaw JC, Levinson W, Montanaro A. Sporotrichosis in the acquired immunodeficiency syndrome. J Am Acad Dermatol. 1989;21(5 pt 2):1145-1147.
23. Fitzpatrick JE, Eubanks S. Acquired immunodeficiency syndrome presenting as disseminated cutaneous sporotrichosis. Int J Dermatol. 1988;27:406-407.
24. Boehm D, Lynch JM, Hodges GR, et al. Disseminated sporotrichosis presenting as sarcoidosis: electron microscopic and immunologic studies. Am J Med Sci. 1982;283:71-78.
25. Satterwhite TK, Kageler WV, Conklin RH, et al. Disseminated sporotrichosis. JAMA. 1978;240:771-772.
26. Matter SE, Bailey DM, Sexton DJ. Immune deficiency presenting as disseminated sporotrichosis. J Okla State Med Assoc. 1984;77:114-117.
27. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis. 1995;21:981-985.
28. Mercurio MG, Elewski BE. Therapy of sporotrichosis. Semin Dermatol. 1993;12:285-289.
29. Schamroth JM, Grieve TP, Kellen P. Disseminated sporotrichosis. Int J Dermatol. 1988;27:28-30.
30. Karakayali G, Lenk N, Alli N, et al. Itraconazole therapy in lymphocutaneous sporotrichosis: a case report and review of the literature. Cutis. 1998;61:106-107.
31. Tay YK, Goh CL, Ong BH. Sporotrichosis: a case report and successful treatment with itraconazole. Cutis. 1997;60:87-90.
32. Conti Diaz IA, Civilia E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses. 1992;35:153-156.
33. Vivani MA, Tortorano AM, Pagano A, et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol. 1990;23:587-593.
34. Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis. 1987;9:S57-S63.
35. Restrepo A, Robledo J, Gomez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol. 1986;122:413-417.
36. Kwon KS, Yim CS, Jang HS, et al. Verrucous sporotrichosis in an infant treated with itraconazole. J Am Acad Dermatol. 1998;38:112-114.
37. Bary P, Kuriata MA, Cleaver LJ. Lymphocutaneous sporotrichosis: a case report and unconventional source of infection. Cutis. 1999;63:173-175.
38. Bolao F, Podzamczer D, Ventin M, et al. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur J Clin Microbiol Infect Dis. 1994;13:609-612.
39. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole: NIAID Mycoses Study Group. Am J Med. 1993;95:279-285.
40. Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis. 1993;17:210-217.
41. Baker JH, Goodpasture HC, Kuhns HR, et al. Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Arch Pathol Lab Med. 1989;113:1279-1281.
42. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis. 2000;30:684-687.